137 related articles for article (PubMed ID: 33129868)
1. Multiparametric Magnetic Resonance Imaging Should Be Preferred Over Digital Rectal Examination for Prostate Cancer Local Staging and Disease Risk Classification.
Soeterik TFW; van Melick HHE; Dijksman LM; Biesma DH; Witjes JA; van Basten JA
Urology; 2021 Jan; 147():205-212. PubMed ID: 33129868
[TBL] [Abstract][Full Text] [Related]
2. Impact of Magnetic Resonance Imaging on Prostate Cancer Staging and European Association of Urology Risk Classification.
Draulans C; Everaerts W; Isebaert S; Gevaert T; Oyen R; Joniau S; Lerut E; De Wever L; Weynand B; Vanhoutte E; De Meerleer G; Haustermans K
Urology; 2019 Aug; 130():113-119. PubMed ID: 31051166
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
4. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Moschini M; Zamboni S; Rakauskas A; Tian Z; Karakiewicz PI; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
Eur Urol; 2020 Jun; 77(6):733-741. PubMed ID: 31547938
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric [11C]Acetate positron emission tomography-magnetic resonance imaging in the assessment and staging of prostate cancer.
Polanec SH; Andrzejewski P; Baltzer PAT; Helbich TH; Stiglbauer A; Georg D; Karanikas G; Susani M; Wadsak W; Margreiter M; Mitterhauser M; Brader P; Pinker K
PLoS One; 2017; 12(7):e0180790. PubMed ID: 28719629
[TBL] [Abstract][Full Text] [Related]
6. Prospective analysis of the diagnostic accuracy of digital rectal examination and magnetic resonance imaging for T staging of prostate cancer.
Zhu J; Wu X; Xue Y; Li X; Zheng Q; Xue X; Huang Z; Chen S
J Cancer Res Ther; 2023 Aug; 19(4):1024-1030. PubMed ID: 37675732
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of multiparametric magnetic resonance imaging in detecting extracapsular extension in intermediate and high - risk prostate cancer.
Dominguez C; Plata M; Cataño JG; Palau M; Aguirre D; Narvaez J; Trujillo S; Gómez F; Trujillo CG; Caicedo JI; Medina C
Int Braz J Urol; 2018; 44(4):688-696. PubMed ID: 29570254
[TBL] [Abstract][Full Text] [Related]
8. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
[TBL] [Abstract][Full Text] [Related]
9. The impact of local staging of prostate cancer determined on MRI or DRE at time of radical prostatectomy on progression-free survival: A Will Rogers phenomenon.
Rakauskas A; Peters M; Ball D; Kim NH; Ahmed HU; Winkler M; Shah TT
Urol Oncol; 2023 Feb; 41(2):106.e9-106.e16. PubMed ID: 36564258
[TBL] [Abstract][Full Text] [Related]
10. Can Radiologic Staging With Multiparametric MRI Enhance the Accuracy of the Partin Tables in Predicting Organ-Confined Prostate Cancer?
Gupta RT; Brown AF; Silverman RK; Tay KJ; Madden JF; George DJ; Polascik TJ
AJR Am J Roentgenol; 2016 Jul; 207(1):87-95. PubMed ID: 27064383
[TBL] [Abstract][Full Text] [Related]
11. The additive value of mpMRI on prostate cancer detection: Comparison between patients with and without a suspicious digital rectal examination (DRE).
Omri N; Alex S; Jacob B; Ofer N
Urol Oncol; 2021 Oct; 39(10):728.e7-728.e11. PubMed ID: 33454199
[TBL] [Abstract][Full Text] [Related]
12. External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging.
Soeterik TFW; Hueting TA; Israel B; van Melick HHE; Dijksman LM; Stomps S; Biesma DH; Koffijberg H; Sedelaar M; Witjes JA; van Basten JA
BJU Int; 2021 Aug; 128(2):236-243. PubMed ID: 33630398
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer.
Salami SS; Vira MA; Turkbey B; Fakhoury M; Yaskiv O; Villani R; Ben-Levi E; Rastinehad AR
Cancer; 2014 Sep; 120(18):2876-82. PubMed ID: 24917122
[TBL] [Abstract][Full Text] [Related]
14. Role of pelvic phased array magnetic resonance imaging in staging of prostate cancer specifically in patients diagnosed with clinically locally advanced tumours by digital rectal examination.
Xylinas E; Yates DR; Renard-Penna R; Seringe E; Bousquet JC; Comperat E; Bitker MO; Grenier P; Rouprêt M
World J Urol; 2013 Aug; 31(4):881-6. PubMed ID: 22193518
[TBL] [Abstract][Full Text] [Related]
15. Radiological Wheeler staging system: a retrospective cohort analysis to improve the local staging of prostate cancer with multiparametric MRI.
Russo F; Manfredi M; Panebianco V; Armando E; De Luca S; Mazzetti S; Giannini V; Mele F; Bollito E; Appendino E; Regge D; Porpiglia F
Minerva Urol Nefrol; 2019 Jun; 71(3):264-272. PubMed ID: 30654601
[TBL] [Abstract][Full Text] [Related]
16. Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up.
Hamoen EHJ; Hoeks CMA; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Bokhorst LP; Witjes JA; Rovers MM; Hulsbergen-van de Kaa CA; Barentsz JO
Eur Urol Focus; 2019 May; 5(3):407-415. PubMed ID: 29331622
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 68Ga-PSMA-I/T PET-CT and Multiparametric MRI for Locoregional Staging of Prostate Cancer Patients: A Pilot Study.
Çelen S; Gültekin A; Özlülerden Y; Mete A; Sağtaş E; Ufuk F; Yüksel D; Yağcı B; Zümrütbaş AE
Urol Int; 2020; 104(9-10):684-691. PubMed ID: 32750695
[TBL] [Abstract][Full Text] [Related]
18. Detection of clinical unilateral T3a prostate cancer - by digital rectal examination or transrectal ultrasonography?
Hsu CY; Joniau S; Oyen R; Roskams T; Van Poppel H
BJU Int; 2006 Nov; 98(5):982-5. PubMed ID: 16945120
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of Multiparametric Magnetic Resonance Imaging for Extracapsular Extension of Prostate Cancer in Community Practice.
Davis R; Salmasi A; Koprowski C; Kim S; Kwon YS; Faiena I; Patel N; Elsamra SE; Kim IY
Clin Genitourin Cancer; 2016 Dec; 14(6):e617-e622. PubMed ID: 27188968
[TBL] [Abstract][Full Text] [Related]
20. Role of Multi-Parametric Magnetic Resonance Image and PIRADS Score in Patients with Prostate Cancer Eligible for Active Surveillance According PRIAS Criteria.
Almeida GL; Petralia G; Ferro M; Ribas CA; Detti S; Jereczek-Fossa BA; Matei DV; Coman I; De Cobelli O; Tagliabue E
Urol Int; 2016; 96(4):459-69. PubMed ID: 27045167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
